Patent Assignment
Reel/Frame 022835/0896
Change of Name
Recorded: 2009-06-18
Pages: 3
Assignor
WARNER CHILCOTT COMPANY, INC.
Executed: 2009-04-13
Assignee
WARNER CHILCOTT COMPANY, LLC
UNION STREET, ROAD 195 KM 1.1, FAJARDO, PUERTO RICO, 00738
Covered Properties
(27)
Oral Pharmaceutical Products Containing 17BETA-Estradiol-3-Lower Alkanoate, Method of Administering the Same and Process of Preparation
Oral Pharmaceutical Products Containing 17BETA-Estradiol-3-Lower Alkanoate, Method of Administering the Same and Process of Preparation
Doxycycline Metal Complex in a Solid Dosage Form
Method of intermittent administration of a pharmaceutical for the treatment of conditions associated with a female's menstrual cycle
Application:
10/819,764 →
Publication:
US US20050038005A1
Method of intermittent administration of a pharmaceutical for the treatment of conditions associated with a female's menstrual cycle
Application:
11/057,843 →
Publication:
US US20050176693A1
Intravaginal Matrix Drug Delivery Devices
Graduated Estrogen Contraceptive
Extended Cycle Multiphasic Oral Contraceptive Method
Estrogen compositions for vaginal administration
Estrogen compositions for vaginal administration
Application:
11/454,473 →
Publication:
US US20070004693A1
Tetracycline metal complex in a solid dosage form
Application:
11/336,551 →
Publication:
US US20060183719A1
Derivative Prodrugs of Ethinyl Estradiol
Gel compositions for topical administration
Application:
11/454,717 →
Publication:
US US20060292223A1
Prodrugs of estradiol
Application:
11/478,584 →
Publication:
US US20070015741A1
Quadraphasis Continuous Graduated Estrogen Contraceptive
Extended Cycle Multiphasic Oral Contraceptive Method
Intravaginal drug delivery devices
Application:
10/564,031 →
Publication:
US US20070043332A1
Methods to Administer Solid Dosage Forms of Ethinyl Estradiol and Prodrugs Thereof with Improved Bioavailability
Application:
11/955,072 →
Publication:
US US20080113953A1
Tetracycline Compositions for Topical Administration
Application:
12/024,723 →
Publication:
US US20080188446A1
Tetracycline Compositions for Topical Administration
Application:
12/024,794 →
Publication:
US US20080188445A1
Intravaginal Drug Delivery Devices for the Delivery of Macromolecules and Water-Soluble Drugs
Extended Estrogen Dosing Contraceptive Regimen
Intravaginal Drug Delivery Devices for the Administration of an Antimicrobial Agent
Oral Pharmaceutical Products Containing 17 Beta-Estradiol-3-Lower Alkanoate, Method of Administering the Same and Process of Preparation
Doxycycline Metal Complex in a Solid Dosage Form
Di-Steroidal Prodrugs of Estradiol
Di-Steroidal Prodrugs of Ethinyl Estradiol
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 26, 2005
From: MULDOON, BRENDAN; LORIMER, COLIN; GILLIGAN, CLAIRE
To: GALEN (CHEMICALS) LIMITED
Reel/Frame 016194/0122 →
Security Agreement
Nov 16, 2009
From: GALEN (CHEMICALS) LIMITED; PROCTER & GAMBLE PHARMACEUTICALS SARL
To: CREDIT SUISSE, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT
Reel/Frame 023519/0430 →
Release - Reel 023519, Frame 0430
Mar 29, 2011
From: CREDIT SUISSSE AG, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT
To: WARNER CHILCOTT (IRELAND) LIMITED (AS SUCCESSOR IN INTEREST TO GALEN CHEMICALS LIMITED); WARNER CHILCOTT PHARMACEUTICALS S.A.R.L. (SUCCESSOR IN INTEREST TO PROCTOR & GAMBLE PHARMACEUTICALS SARL
Reel/Frame 026042/0220 →
Release - Reel 023456, Frame 0052
Mar 29, 2011
From: CREDIT SUISSSE AG, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT
To: WARNER CHILCOTT COMPANY LLC
Reel/Frame 026042/0046 →
Security Agreement
Mar 30, 2011
From: WARNER CHILCOTT (IRELAND) LIMITED
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 026065/0215 →
Change of Name
Jul 13, 2011
From: GALEN (CHEMICALS) LIMITED
To: WARNER CHILCOTT (IRELAND) LIMITED
Reel/Frame 026584/0948 →
Release of Security Interest
Oct 9, 2013
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: WARNER CHILCOTT (IRELAND) LIMITED
Reel/Frame 031394/0587 →
Release of Security Interest
Oct 31, 2013
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: WARNER CHILCOTT COMPANY, LLC
Reel/Frame 031531/0538 →
Assignment of Assignor's Interest
Sep 29, 2016
From: WARNER CHILCOTT COMPANY, LLC
To: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Reel/Frame 040183/0129 →
Assignment of Assignor's Interest
Sep 29, 2016
From: WARNER CHILCOTT (IRELAND) LIMITED
To: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Reel/Frame 039897/0584 →
Corrective Assignment to Correct the Us Patent No. 8,050,873 Previously Recorded on Reel 040183 Frame 0129. Assignor(S) Hereby Confirms the Assignment.
Feb 22, 2018
From: WARNER CHILCOTT COMPANY, LLC
To: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Reel/Frame 045417/0593 →
Assignment of Assignor's Interest
Sep 27, 2021
From: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
To: ALLERGAN THERAPEUTICS LLC
Reel/Frame 057605/0461 →